📰 Nasdaq Pcvx News
Page 5 - Nasdaq Pcvx News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Pcvx. Real-time updates on events, politics, business and more.
June 3, 2023
Vaxcyte (NASDAQ:PCVX – Get Rating) and REGENXBIO (NASDAQ:RGNX – Get Rating) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, analyst recommendations, profitability, institutional ownership and risk. Profitability This table compares Vaxcyte and REGENXBIO’s net margins, return on equity […]
June 3, 2023
Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) has been given an average recommendation of “Buy” by the eight brokerages that are presently covering the stock, Marketbeat.com reports. Five research analysts have rated the stock with a buy rating. The average 12 month price objective among brokers that have covered the stock in the last year is […]
May 26, 2023
Opaleye Management Inc. reduced its stake in Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) by 6.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 177,000 shares of the company’s stock after selling 13,000 shares during the period. Vaxcyte makes up 3.0% of Opaleye Management […]
May 22, 2023
Tekla Capital Management LLC purchased a new position in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) during the fourth quarter, HoldingsChannel reports. The institutional investor purchased 5,000 shares of the company’s stock, valued at approximately $240,000. Other large investors also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC […]
May 22, 2023
Sectoral Asset Management Inc. purchased a new stake in Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 60,000 shares of the company’s stock, valued at approximately $2,877,000. Sectoral Asset Management Inc. owned about 0.08% […]
May 16, 2023
Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) have been given an average recommendation of “Buy” by the eight ratings firms that are covering the stock, Marketbeat reports. Five research analysts have rated the stock with a buy rating. The average 12-month price target among brokerages that have issued ratings on the stock in the […]
May 12, 2023
888 reiterated their reiterates rating on shares of Vaxcyte (NASDAQ:PCVX – Get Rating) in a report published on Tuesday morning, Benzinga reports. Other equities research analysts also recently issued reports about the stock. Needham & Company LLC reissued a buy rating and set a $58.00 price target on shares of Vaxcyte in a research note […]
May 12, 2023
Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) – Equities researchers at Cantor Fitzgerald boosted their FY2023 EPS estimates for shares of Vaxcyte in a report issued on Tuesday, May 9th. Cantor Fitzgerald analyst L. Chen now expects that the company will earn ($3.15) per share for the year, up from their prior estimate of ($3.93). The […]
May 9, 2023
Vaxcyte (NASDAQ:PCVX – Get Rating)‘s stock had its “reiterates” rating restated by analysts at 888 in a report issued on Tuesday, Benzinga reports. A number of other equities research analysts have also issued reports on PCVX. Bank of America upped their target price on Vaxcyte from $63.00 to $68.00 in a research note on Monday, […]
May 9, 2023
Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) has been assigned an average recommendation of “Buy” from the eight brokerages that are currently covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have issued a report on the stock in the last […]